Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
The American College of Rheumatology (ACR) has issued new guidelines for treating juvenile idiopathic arthritis (JIA) that emphasize the use of ... Read more
The U.S. Food and Drug Administration (FDA) has approved Janssen‘s Simponi Aria (golimumab) for the treatment of active polyarticular juvenile idiopathic ... Read more
The U.S. Food and Drug Administration (FDA) has approved Hulio, a biosimilar of Humira (adalimumab), for the treatment of juvenile idiopathic arthritis (JIA) in ... Read more
Janssen has submitted two new applications to the U.S. Food and Drug Administration (FDA) seeking approval for Simponi Aria (golimumab), in combination ... Read more
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Nepexto, a biosimilar of Enbrel (etanercept), for the ... Read more
Asian mothers with juvenile idiopathic arthritis (JIA) are not at greater risk of pregnancy- or birth-related complications than mothers without the ... Read more
